Back to News
Market Impact: 0.22

CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

Source: Nasdaq

Cybersecurity & Data PrivacyArtificial IntelligenceCompany FundamentalsAnalyst InsightsCorporate EarningsCorporate Guidance & Outlook
CrowdStrike vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

CrowdStrike is presented as the preferred long-term software investment despite its premium valuation, trading at 146.6x forward P/E and 39.3x sales versus UiPath at 15.9x and 4.2x, respectively. CrowdStrike generated nearly $4.8B in FY2026 revenue, up 21.7%, but recorded a $162.5M net loss; UiPath generated roughly $1.6B, up 12.7%, and achieved $282.3M of net income, a 17.5% margin. The bullish CrowdStrike case rests on record ARR, free cash flow nearing one-third of revenue, OpenAI and Amazon partnerships, and expanding AI-related cybersecurity demand, while legal exposure from its 2024 outage remains a key risk.

Analysis

The relevant setup is not simply growth versus value: CRWD is priced as a durable consolidation winner, leaving little room for execution slippage, while PATH is priced as a challenged software asset despite evidence that operating leverage can emerge. CRWD's key sensitivity is net-new module adoption and retention; any deceleration in net retention, large-customer expansion, or billings would pressure a premium revenue multiple disproportionately. Its AI partnerships are strategically useful but should not be capitalized as near-term revenue without disclosed attach rates or contract economics.

PATH's profitability inflection deserves scrutiny because both firms' cash-flow optics are materially affected by stock compensation. The investable question over the next 1-3 quarters is whether PATH can sustain margin gains while reaccelerating recurring revenue and retain large accounts through its product transition. If it can, the valuation gap creates asymmetric rerating potential; if growth remains low-teens or customer concentration produces a single material downgrade, the market will treat recent profitability as cost-cutting rather than a durable platform shift.

Competitive dynamics favor larger ecosystem vendors in agentic automation: MSFT, NOW, CRM and AMZN can bundle workflow, data, identity and AI capabilities into existing enterprise contracts. That makes PATH's acquisitions a possible route to higher-value compliance workflows, but also raises integration and sales-execution risk. Conversely, cybersecurity spend is less discretionary than automation spend, making CRWD relatively defensive in a macro slowdown, though a renewed reliability or legal-development headline could reopen vendor-consolidation risk in favor of PANW, FTNT and MSFT.

Contrarian view: the article's preference for CRWD likely reflects a consensus quality trade rather than a fresh catalyst. The better risk-adjusted expression is to own CRWD only against a short in a security peer or software basket, while treating PATH as an event-driven re-rating candidate contingent on independently verified ARR, retention and margin durability rather than headline EPS beats.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.32

Ticker Sentiment

AMZN0.10
CRWD0.62
PATH0.30

Key Decisions for Investors

  • Do not add outright CRWD at current premium valuation absent a pullback or a quarterly acceleration in net-new ARR/billings. Prefer a 3-6 month long CRWD / short IGV pair to retain cybersecurity-share upside while reducing duration and enterprise-software multiple risk.
  • Establish a starter long PATH only ahead of or following the next earnings report if management demonstrates recurring-revenue reacceleration and maintains GAAP profitability; target a 6-12 month re-rating, with sizing capped until top-customer concentration and acquisition integration metrics are disclosed.
  • Use PANW or MSFT as the primary competitive hedge against CRWD-specific execution or reliability risk. A material reduction in CRWD retention, a weaker billings guide, or adverse legal/reputational development should trigger exit from the CRWD leg rather than averaging down.
  • For PATH, invalidate the long thesis if growth slips below low-teens without offsetting durable gross-margin expansion, if a major-client loss emerges, or if profitability reverses after integration costs. In that case, avoid the value trap and favor MSFT/NOW exposure to enterprise AI workflow spending.
  • Watch the next 1-3 months of enterprise IT-budget commentary and cloud-security demand from AMZN and major SaaS vendors. Broad discretionary-software budget tightening would favor the CRWD-versus-PATH relative trade, while evidence of agentic-workflow deployment converting into paid production workloads would be the catalyst to increase PATH.

More News

From AllMind Research

Browse all research